Canakinumab for the Prevention of Recurrences After Electrical Cardioversion: CONVERT-AF
Clinical trial NCT01805960 · TERMINATED
Trial details
- NCT number
- NCT01805960
- Sponsor
- University Hospital, Basel, Switzerland
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-06-01
- Primary completion
- 2016-12-01
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.